Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 12-2018 | 03-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 32,570 | 0 | 40,755 | 37,490 |
| Marketable Securities | N/A | 59,614 | 0 | 50,085 | 53,003 |
| Receivables | N/A | 0 | 0 | 111,266 | 111,318 |
| Income taxes - deferred | N/A | N/A | N/A | 8,597 | 9,024 |
| Other current assets | 0 | 1,119 | 0 | 29,050 | 29,001 |
| TOTAL | $N/A | $93,303 | $0 | $239,753 | $239,836 |
| Non-Current Assets | |||||
| PPE Net | N/A | 4,167 | N/A | 69,804 | 71,511 |
| Investments And Advances | 0 | 4,762 | 0 | 2,036 | 4,881 |
| Intangibles | 0 | 0 | 0 | 361,018 | 365,282 |
| Other Non-Current Assets | 0 | 427 | 0 | 42,173 | 41,580 |
| TOTAL | $N/A | $9,356 | $N/A | $475,031 | $483,254 |
| Total Assets | $N/A | $102,686 | $0 | $714,784 | $723,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,506 | 0 | 14,427 | 13,194 |
| Accrued Expenses | N/A | 818 | 0 | 67,799 | 74,646 |
| Other current liabilities | N/A | 88 | 0 | N/A | N/A |
| TOTAL | $N/A | $2,697 | $0 | $232,400 | $238,177 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 25,217 | 54,696 |
| Deferred Revenues | N/A | N/A | N/A | 150,174 | 150,337 |
| Other Non-Current Liabilities | 0 | 74 | 0 | 7,906 | 8,763 |
| TOTAL | $N/A | $74 | $N/A | $64,470 | $94,248 |
| Total Liabilities | $N/A | $2,982 | $0 | $296,870 | $332,425 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 32,306 | 31,665 |
| Common Shares | N/A | 6 | 0 | 322 | 317 |
| Retained earnings | N/A | -23,462 | 0 | 334,072 | 325,129 |
| Other shareholders' equity | 0 | 122,889 | 0 | 2,233 | 1,979 |
| TOTAL | $N/A | $99,704 | $0 | $417,914 | $390,665 |
| Total Liabilities And Equity | $0 | $102,686 | $0 | $714,784 | $723,090 |